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Summary Two retrovirus vectors were compared for their ability to express granulocyte-macrophage colony
stimulating factor (GM-CSF) in a haematopoietic cell line, FDCPI, which is dependent on GM-CSF for
survival. Both a MoMLV-based vector pVneoGM, and a MPSV-based vector, M3neoGM, were found to be
capable of transmitting and expressing both GM-CSF and neomycin sequences in the myeloid FDCPI cell
line. Our results also demonstrate that pVneoGM is more efficient at generating GM-CSF independent
colonies than M3neoGM. Analysis of cell lines derived after infection confirmed pVneoGM expressed higher
levels of GM-CSF. Cell lines generated by infection with pVneoGM responded to levels of exogenous
recombinant GM-CSF which did not stimulate growth of the parental cell line, suggesting autocrine stimula-
tion may convey a proliferative advantage under sub-optimal growth conditions. Finally the parental vectors
pVneo and M3neo were shown to be capable of expressing the neomycin gene in both murine haematopoietic
progenitor and stem cells.
The clonal growth of haematopoietic cells in vitro relies on a
group ofproteins referred to as colony stimulating factors, or
growth factors (Metcalf, 1984). Clonogenic assays have
identified the target cell populations and physiological
actions of many colony stimulating factors (Metcalf, 1984)
and it seems that it is the ability of growth factors to
maintain cell viability, trigger proliferation and direct
differentiation patterns that make growth factors ideal can-
didates as the molecules that regulate haematopoiesis in vivo
(Metcalf, 1984; Sieff, 1987). Indeed, the perturbation of
growth factor biochemistry could be a contributory factor in
the multistep process of leukaemogenesis and may release a
haematopoietic cell from normal growth restraints thus con-
veying a growth advantage to the cell (Eaves et al., 1986;
Gordon et al., 1987; Heard et al., 1984; Gisselbrecht et al.,
1987).
The haematopoietic growth factor GM-CSF can maintain
the survival of relatively primitive multipotential cells (Met-
calf et al., 1980, 1986) and is capable of directing the
differentiation of progenitor cells down the granulocyte and
macrophage lineages (Metcalf, 1980). Although the expres-
sion of GM-CSF is not detected in normal myeloid cells,
GM-CSF mRNA and activity has been detected in the
haematopoietic tissue from a number of patients with acute
myeloid leukaemia (AML) (Young & Griffin, 1986; Young et
al., 1987). In some of these samples, the autocrine production
of growth factor permits cells to grow clonally in the absence
of exogenous growth factor (factor independent). Both Laker
et al. (1987) and Lang et al. (1985) have shown that introduc-
tion of a GM-CSF cDNA into the GM-CSF dependent
myeloid cell line, FDCP1, which is dependent on either GM-
CSF or IL-3 for its survival (Dexter et al., 1980) results in
factor independent cell growth. The introduction of a GM-
CSF cDNA into haematopoietic cells, therefore, allows a
direct means of testing the potential of growth factors to
contribute to the leukaemic process.
In this study, we have compared the ability of two re-
troviral vectors to express GM-CSF in the factor dependent
FDCP1 cell line (Dexter et al., 1980). Retroviral vectors
based on Moloney murine leukaemia virus (MoMLV) have
been used to infect haematopoietic cells with some success
(Lemischka et al., 1986; Dick et al., 1985). However, despite
their ability to infect haematopoietic cells they are relatively
inefficient in expressing long terminal repeat (LTR) driven
sequences in these cells (Joyner et al., 1983; Williams et al.,
1986; Mclvor et al., 1987). Myeloproliferative sarcoma virus,
(MPSV) has a broader host range than MoMLV and is an
ideal candidate from which to derive retroviral vectors
(Stocking et al., 1986; 1985). It is important to understand
the mechanism whereby different vectors express genes, as
this will be reflected in the interpretation of the biological
effects. We show that the retroviral vector based on MoMLV
is more efficient at expressing GM-CSF in haematopoietic
cells and that this vector is suitable for reintroduction of
genes into haematopoietic stem cells.
Materials and methods
Cell culture and cell lines
Murine 3T3 fibroblasts, Y2 (Mann et al., 1983) and 'IAM
(Cone & Mulligan, 1984) packaging cell lines and FDCP1
cells (Dexter et al., 1980) were grown in supplemented
modified Eagles medium (SLM, Gibco 043-01136M), 10%
fetal calf serum, 2 mM glutamine. The FDCP1 cell line was
passaged in the presence of conditioned medium from the
WEHI3B cell line as a source of IL-3 to a final concentration
of 10% (Dexter et al., 1980). The FDCP1 cell line also
proliferates in response to GM-CSF (Lang et al., 1985; Laker
et al., 1987). In FDCP1 clonogenic asays, rGM-CSF
stimulates maximal colony formation at between 219 to
875 pg ml-' (data not shown). Fibroblast cell lines containing
the neomycin gene were selected and maintained in
800 ,g ml-' of geneticin. The FDCP1 cell line was selected
and maintained in 1 mg ml- geneticin.
Generation ofvirusproducing cell lines
Stable transfection of plasmids into the '2 cell line was
achieved by calcium phosphate co-precipitation (Graham &
Van der Ebb, 1973). One pg of plasmid was mixed with 20 Ag
of sheared genomic carrier DNA and the DNA/CaPO4
precipitate was left on the cells overnight. The medium was
then changed and the cells were incubated for a further 48-h
expression period before selection in 800 jigml-' geneticin.
Geneticin-resistant colonies were identified two weeks later
and cell lines established from which virus stocks could be
collected. Alternatively, the plasmids were transfected tran-
siently in the presence of DEAE-dextran (Sompayrac &
Danna, 1981) into the amphotropic virus packaging cell line
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PAM. Cells were exposed to 5-25fig plasmid for 1 h. After a
48-h expression period, culture medium containing virus
particles was removed, passed through a 0.45 t filter and
used immediately to infect the P2 packaging cell line.
Geneticin-resistant P2 virus-producing cell lines were then
established.
Virus infection (Magli et al., 1987; Mulligan, 1983)
Virus-containing medium was harvested from virus-
producing cell lines reseeded 24 h previously at 5 x 105 cells
per 25 cm2, flask, passed through a 0.451I filter and used
immediately or stored at -20°C for up to 1 month. Fibro-
blasts to be infected were seeded out at 5 x 105 cells per
25 cm2 flask one day before infection. The fibroblasts were
exposed to an aliquot of virus (usually 50gAl) for 24 h in the
presence of 6fig ml-' polybrene after which the cells were
washed and incubated for a further 48 h. Cells were then
replated at 5 x I05 cells per 10cm petri dish in medium
containing geneticin at a concentration of 800fg ml ' with
at least 3 dishes per point. Infected cells were incubated for 2
weeks after which colonies were counted. Virus titre was
calculated taking into account the replating efficiency of the
cells during the experiment. Bone marrow cells harvested as
previously described (Pragnell et al., 1988) and FDCP1 cells
were exposed to virus by co-cultivation with virus-producing
cells seeded out 24 h previously at 5 x 105 cells per 25 cm2
flask. Polybrene was added at 6jg ml-' and WEHI-3B con-
ditioned media to 10% (FDCP1 cells) or 2% (bone marrow
cells). Co-cultivation took place for 24 h after which non-
adherent cells were recovered. The non-adherent cells were
washed twice in PBS to remove polybrene and growth factors
before replating. For infections of primary bone marrow
cells, after co-cultivation, only non-adherent cells were
recovered. Nucleated cells were counted and the appropriate
numbers ofcells used for the clonogenic assays (see Materials
and methods CFU-GM progenitor assay and CFU-A primitive
progenitor assay).
Clonogenic assaysfor haematopoietic cells
FDCPI clonogenic assay Infected FDCP-1 cells were re-
plated into 0.3% agar or 0.9% methocellulose in sup-
plemented alpha modified MEM containing 25% fetal calf
serum at the desired cell density. WEHI-3B conditioned
media was added to the dishes at 10% final volume and
geneticin at I mg ml-'. The titration of recombinant GM-
CSF in the FDCP1 clonogenic assay showed maximal colony
formation between 219 to 875 pg ml' with a replating
efficiency of 16%. Colonies were counted after two weeks.
CFU-GM progenitor assay and CFU-A primitive progenitor
assay (Pragnell et al., 1988) CFU-GM were assayed by
culturing 1-5 x 104 cells per 3 cm petri dish containing 0.3%
agar on 0.9% methocellulose in supplemented alpha modified
MEM containing 25% fetal bovine serum. Conditioned
media from the AF1-19T or WEHI-3B cell lines were used as
sources of colony stimulating factor. For detection of CFU-
A, 104 cells in 4 ml supplemented alpha modified MEM
containing 25% fetal bovine serum in 0.3% agar or 0.9%
methocellulose were incubated in the presence of 10% L929
conditioned media and AFI-19T (Pragnell et al., 1988) condi-
tioned media in 6 cm petri dishes. Plates were incubated for 7
days for detection of CFU-GM and 11 days for detection of
CFU-A colonies. Geneticin was added at 1.5 mgml-'.
Plasmids
The plasmids used in this study are shown in Figure 1.
M3neo (Laker et al., 1987) and M3neoGM were gifts from
W. Ostertag. The GM-CSF cDNA insert (Gough et al.,
1985) in M3neoGM was removed by digesting plasmid DNA
with BamHI and purifying the insert. The BamHI GM-CSF
fragment was then ligated into BamHI digested pVneo. The
resultant construct was called pVneoGM. The plasmid pV200
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Figure 1 Retroviral constructs. a, pVneo contains a unique Bam
HI cloning site five prime to the thymidine kinase promoter. It is
derived from Moloney murine leukaemia virus. b, pVneoGM was
generated by digestion of pVneo with Bam HI and ligation to a
Bam HI GM-CSF fragment from M3neoGM. The transcrip-
tional orientation of the insert is shown by an arrow. c, M3neo
contains a unique Bam HI cloning site three prime to the
neomycin gene. It is derived from myeloproliferative sarcoma
virus. d, M3neoGM is a GM-CSF carrying counterpart of
M3neo. Transcriptional orientation of the inserts are shown by
arrows. All sizes are in base pairs. NEO, neomycin gene from
TN5. LTR, Viral Long terminal repeat. TK, Thymidine Kinase
promoter. GMA7, GM-CSF complementary DNA sequences.
s.d. Viral splice donor sequence. s.a Viral splice acceptor
sequence.
neo (Episkopou et al., 1984) has been renamed in this study
as pVneo, for ease of description.
Molecular analysis ofcell lines
Genomic DNA and total cellular RNA were extracted by the
method of Kreig et al. (1983). DNA samples were digested
with restriction enzymes under the manufacturers recom-
mended conditions and resolved by electrophoresis in 0.8%
agarose gels containing Tris-acetate buffer. RNA samples
(20;Lg) were resolved by electrophoresis in 1.4% agarose gels
containing formaldehyde and MOPS buffer (0.04 M
morpholinepropane-sulphonic acid, 0.01 M sodium acetate,
1 mM EDTA, pH 7.5). Nucleic acids were transferred to
Genescreen (Du Pont) membranes. Filters were probed with
[a-32P] dCTP labelled, random primed 1 kb BglII/SmaI frag-
ment from the neomycin phosphotransferase gene. Hybridisa-
tion was carried out in 50% (v/v) formamide, 5 x SSC,
5 x Denhardts solution, 25 mM phosphate buffer, 0.1% w/v
SDS and 100fig ml-' of denatured salmon sperm DNA at
42°C overnight.390 W.N. KEITH et al.
Results
Transfer ofMoMLV and MPSVbased retroviral vectors into
fibroblast and haematopoietic cells
Figure 1 shows the retroviral constructs used in this study.
The MoMLV based vector, pVneoGM, expresses the GM-
CSF sequences directly from the viral LTR while expression
of the neomycin gene is due to the thymidine kinase pro-
moter (Episkopou et al., 1984). The retroviral vector
M3neoGM relies on the viral LTR for expression of both the
neomycin gene and GM-CSF sequences (Laker et al., 1987).
GM-CSF will be either translated from a subgenomic viral
transcript, as this vector retains viral splice donor and accep-
tor sequences, or as the second cistron of a bicistronic mes-
sage.
The virus titres on NIH 3T3 fibroblasts rangd from 104 to
greater than I05 geneticin-resistant (G418') cfu ml-'. Virus
from all 4 vectors were capable of infecting the FDCP1 cell
line, as measured by geneticin resistance (Table I). However,
the MPSV vector M3neo was consistently 10-fold more
efficient at infecting FDCP1 cells although there were no
obvious differences in titre between the MoMLV or MPSV
based vectors on NIH 3T3 fibroblasts.
Selection ofvirally infected FDCP1 cells for colony growth
in the absence of exogenous growth factor (factor
independence) demonstrates that the GM-CSF containing
vectors express GM-CSF in the FDCP1 cells (Table I -G418,
-WEHI-CM). Factor independence is a direct consequence of
expression of the GM-CSF sequences, as infection with the
parental neo viruses did not generate any factor independent
colonies after infecton of an equivalent number of cells.
From Table I it can be seen that pVneoGM virus generated
18-fold more factor independent colony than the M3neoGM
virus. Since these vectors have equivalent titres on 3T3 and
FDCP1 cells as determined by geneticin resistance,
differences in,frequency with which they convert FDCPI cells
to factor independence must be related to their two different
modes of GM-CSF expression.
Growthfactor releasefrom T2 cells harbouring GM-CSF
vectors
Table II shows that conditioned medium from T2 cells con-
taining the retroviral GM-CSF constructs stimulated colony
Table I Retroviral infection of FDCP-1 cell line
Relative platingb
Efficiency ofFDCP-1 cells (%)
G418 c.fua +-G418 -G418
Virus Clone 3T3 cells + WEHI-CM - WEHI-CM
pVneo 1 >10i 8 (32) <3.6 x 10-2
pVneo 2 >105 4 (4) <3 x 10-3
pVneoGM 3 2.8 x 104 2.5 (10) 1.8
M3neo 4 5.3 x 105 60 (39) <2.6 x 10-3
M3neo 5 2 x 105 49 (20) <5.6 x 10-3
M3neoGM 6 5.3 x 104 5 (33) 0.1
aTitre expressed as number of G418 resistant colony forming units
(G418 cfu) per millilitre ofproducer clone supernatant assayed on 3T3
fibroblasts. bRelative plating efficiency is the ratio ofcolony formation
under selective conditions to colony formation under non-selective
conditions (replating efficiency), expressed as a percentage. The
numbers in brackets are the replating efficiencies ofthe cell lines under
non-selective conditions expressed as a percentage. Non-selective
conditionsinsemi-solidmediainclude 10% WEHIconditionedmedium
(WEHI-CM) but no geneticin. Selective conditions for neomycin
expression areinclusion of10% WEHI-CM andgeneticinat I mgml-'.
Selective conditions forgrowth factor independent colony formation is
theabsence ofWEHI-CM andgeneticin from the semi-solid medium. If
no colony growth is observed the relative platingefficiency is expressed
as less than if one colony had been scored under selective conditions.
Eachcloneisanindependentexperiment representative ofalargerseries
ofinfections. At least 3 1 cm diameter dishes were used per point. At
least 50 colonies were counted per plate on control plates.
formation from bone marrow progenitors, whereas cells con-
taining the vector alone did not. The colony stimulating
activity released from the GM-CSF containing cells could be
neutralised by antiserum to GM-CSF (DeLamarter et al.,
1985), confirming the colony stimulating activity released is
GM-CSF. Cells expressing pVneoGM released considerably
more GM-CSF than cells expressing M3neoGM. A cell line
harbouring M3neoGM released barely detectable levels of
colony stimulating activity, despite the packaging cells ability
to produce virus which could generate factor independent
colony growth at a low frequency, after infection of FDCP1
cells (Table I).
Growthfactor independence ofFDCPI cell lines generated by
viral infection
Geneticin-resistant FDCP1 cell lines containing each of the 4
vectors were established in the presence of conditioned
medium from the WEHI 3B cell line. These cell lines were
tested for their ability to grow in a factor independent man-
ner. Of the 6 cell lines tested which were infected with
pVneoGM, 5 demonstrated clonal growth in the absence of
exogenous growth factor. None of the FDCP1 cell lines
which harboured the parental viral constructs could form
colonies when replated in the absence of exogenous growth
factor (Table III). Figure 2 shows that the correct transcripts
corresponding to full length viral RNA and the shorter
thymidine kinase promoter driven transcript are present in
pVneo and pVneoGM infected FDCP1 cells, except in the
single clone which did not replate into factor independent
conditions (clone 12). This clone has no full length viral
transcript which encodes the GM-CSF protein (Figures 1 and
2). DNA extracted from FDCP1 clones was digested with a
restriction enzyme which cuts once within each viral LTR
and analysed by Southern blot hybridisation (Figure 3). Cell
lines infected with pVneoGM contain a 4.2 kb neo
hybridising fragment corresponding to the expected size of
the provirus, except for clone 12 which appears to contain a
rearranged provirus (Figure 3).
Table III demonstrates that the replating of 4 cell lines
containing M3neoGM in factor independent conditions
reveals their inability to form colonies even when plated at
104 cells ml-'. Therefore, it is possible that, despite infection
with a GM-CSF virus, the levels of expression of the GM-
CSF sequences in many clones is not sufficient to allow
factor independent colony growth.
The generally low and variable replating efficiency of the
pVneoGM containing cell lines in factor independent cond-
itions suggests that the level of autocrine secretion may not be
high enough to efficiently sustain factor independent colony
growth. To test whether cell lines generated after infection
with pVneoGM were still responsive to exogenous growth
factor and therefore not maximally stimulated by autocrine
produced GM-CSF, a low level of recombinant GM-CSF
(rGM-CSF) (De Lamarter et al., 1985) was added to the
culture plates. Table IV shows that the two clones are still
responsive to exogenously aded rGM-CSF and their replating
efficiencies are increased by its presence, while no such effect
is observed on the parental FDCP1 cell line.
Infection ofmurine bone marrowprogenitors andstem cells
To examine the feasibility of using these vectors to express
GM-CSF in primary murine progenitor and stem cells, the
parental neo viruses were used to infect bone marrow cells.
The two in vitro assays used were the CFU-GM progenitor
assay (Pragnell et al., 1988; Metcalf, 1984) and the CFU-A
stem cell assay. Table V shows both M3neoGM and pVneo
viruses could confer resistance to geneticin in murine pro-
genitor and stem cell assays; 20-75% of clonogenic cells
appear to be infected by these viruses as assayed by geneticin
resistance. Examples of geneticin resistant CFU-A colonies
are shown in Figure 4. Therefore, these vectors would be
suitable candidates for the introduction of GM-CSF in
primary murine bone marrow cells.RETROVIRUS EXPRESSION OF GM-CSF 391
Table II Growth factor release from '2 cells
Anti-serum ColoniesilOs cells
Vector Clone against GM-CSF plated
pVneo 2 - 0
pVneoGM 3 - 52
+ 0
pVneoGM 7 - 34
+ 0
M3neo 4 - 0
M3neoGM 6 - 2
+ 0
recombinant GM-CSF 34
+ 0
5 x I05 virus producercells were seeded into 25 cm2 flasksin 5 ml medium. After3 days
themediumwasremovedandfiltered.Three-dayconditionedmedium(CM)from'F2virus
producer clones was assayed for growth factor activity using the CFU-GM progenitor
assay. 100ftl of the test CM was added to 3 cm petri dishes and overlayed with 1 ml of
0.3% soft agarcontaining 7.5 x 104nucleated bone marrowcells. Antiserum and test CM
were incubated for 30 min at 37°C before addition to theculture dish. Colonies ofgreater
than 30cells werecounted after 7days. Each CM was tested twicewith at least two dishes
each experiment and the results averaged. Recombinant GM-CSF (De Lamarter et al.,
1985) at 875 pg ml-' was used as a control.
Table III Colony formation in semi-solid medium of G418 resistant FDCP1 cell lines generated by
infection with retroviral vectors
Relative Platinga Relative Platinga
Efficiency (%) Efficiency (%)
+ G418 -G418 + G418 -G418
Virus Clone + WEHI-CM - WEHI-CM Virus Clone + WEHI-CM - WEHI-CM
pVneo 1 124 (25) 0 M3neo 13 180 (5) 0
2 50 (10) 0 14 100 (11) 0
3 114 (5) 0 15b TNTC (44) 0
4 98 (15) 0 16b TNTC (7) 0
5 200 (4) 0
6 160 (2) 0
pVneoGM 7 77 (33) 60 M3neoGM 17 93 (5) 0
8 20 (15) 7.5 18 121 (5) 0
9 72 (17) 15 lgb TNTC (41) 0
10 107 (7) 10 20b TNTC (6) 0
11 58 (22) 4
12 70 (7) 0
Individual geneticin-resistant colonies generated after infection with the vectors were picked and
maintained under selective conditions. 'Relative plating efficiency is the ratio of colony formation under
selectiveconditions tocolonyformationundernon-selectiveconditionsasinTableII. Replatingefficiencyof
the cell lines under non-selective conditions are shown in brackets as a percentage.
The cells were plated out at I03 cells ml-'except forb which were plated out at I04 cells ml-'. Three 3 cm
platescontaining 1 mlofsemi-solidmediumwereusedperpoint. TNTCcolonynumbersweretoo numerous
to count. At least 50 colonies per control plate were counted.
Table IV Response of pVneoGM infected FDCP-1 cells to exogenous GM-CSF
Relative plating
efficiency (%)
Replating -G418
Cell density4 efficiency (%) + G418 - G418 + 0.1%
Clone (ml) in WEHI-CM + WEHI-CM - WEHI-CM rGM-CSF
Parental 5 x 104 20 0 0 0
FDCP-1
21 5x 103 4.5 130 13 46
22 5x103 0.5 158 17 75
Two clones harbouring the pVneoGM virus were plated out under non-selective and
selective conditions as in Tables II and III. rGM-CSF = recombinant GM-CSF
rGM-CSF (De Lamarter et al., 1985) was added to the dishes to a final concentration of
0.875 pgml-' (0.1% rGM-CSF). The amount of rGM-CSF added was determined by
titration ofrGM-CSF in a FDCPI clonogenic assay (data not shown). Maximal FDCPI
colonyformation wasbetween 219to875 pg ml-' rGM-CSF. aTriplicate 3 cmpetri dishes
containing I ml ofsemi-solid medium and the appropriate cell density were used foreach
point.392 W.N. KEITH et al.
Table V Infection ofbone marrow progenitor and stem cells detected
using in vitro colony forming assays
A. CFU-GM progenitor cells
Virus
18S-
1 2 3 4 5 6 7 8
Figure 2 Northern blot analysis of RNA extracted from FDCPI
cell lines. Lane 1, parental FDCPI cell line. Lanes 2-4, cell lines
infected with pVneo. Lanes 5-8, cell lines infected with
pVneoGM. Lane 7 contains RNA from clone 12. The mobilities
of the 28S and 18S ribosomal mRNAs are marked.
pVneo
M3neo
M3neo
Control
Control
B. CFU-A stem cells
Virus
pVneo
M3neo
M3neo
Control
Control
15-
9.5- m;
6.7-
,,,z,,s,.C,,#l:i~~~~~....... -:--- -- --
1 2 3 4 5 6 7
Figure 3 DNA blot hybridisation analysis of proviral sequences.
All DNAs digested with Sstl, which cuts once within each LTR.
Lane 1, parental FDCPI DNA. Lanes 2-4, DNA from cell lines
harbouring pVneo. Lanes 5-7, DNA from cell lines harbouring
pVneoGM. Lane 7 is DNA extracted from clone 12. Sizes are in
kilobases.
A. Infection of CFU-GM progenitor cells. B. Infection of CFU-A
stem cells. aGeneticin was added at a concentration of I mgml-' or
1.5 mgml1' for infections using pVneo and M3neo respectively.
1-2 x I07 nucleated bone marrow cells were incubated for 24 h with
the virus producer cell lines. After 24h, non-adherent cells were
removed. For infections using pVneo the cells were plated out directly
with orwithout geneticin in0.3% soft agar. Ten 10 cmpetri dishes were
used per point for the CFU-A assay under geneticin selection, 5 10 cm
plates per point for the unselected controls. Five 3 cm plates were used
per point in the CFU-GM assay.
For infections using M3neo, after 24 h co-cultivation, non-adherent
cells were removed to a fresh 25 cm2 flask and incubated for a further
48 h in the presence of 2 mg ml' of geneticin, 2% WEHI-CM.
Non-adherent cells were then plated out in the CFU-A assay using at
least 3 6 cm petri dishesperpointand the CFU-GM assayusing at least
3 3 cm dishes per point.
Discussion
Retroviral vectors have been shown to infect primitive
haematopoietic cells and integrate into the host genome with
a high efficacy (Dick et al., 1985; Lemischka et al., 1986), yet
levels of viral expression are disappointingly low (Joyner et
al., 1983; Williams et al., 1986; Mclvor et al., 1987). It is
convenient to assess the efficiency of retroviral mediated gene
expression in haematopoietic cell lines. Two previous studies
(Lang et al., 1985; Laker et al., 1987) used the FDCP1 cell
line as a recipient for GM-CSF containing retroviral vectors.
The study by Lang et al. (1985) relied on the splice type
vector pZIPneoSV (X) 1, whereas Laker et al. (1987) used
mainly the MPSV based splice type vector M3neo. GM-CSF
independent cell lines generated by these two studies differed
in that, in contrast to cell lines studied by Laker et al. (1987),
those studied by Lang et al. (1985) did not require the release
of autocrine produced GM-CSF in order to stimulate cell
proliferation. It is possible that these results do not con-
tradict one another but differ owing to the vector used to
express the GM-CSF sequence, and thus the levels of GM-
CSF protein produced.
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of the dishes is 6 cm. A mock infection without geneticin. B,
mock infection plus 1.5 mg ml- geneticin included in the semi
solid-medium. C, Infection with M3neo without geneticin. D,
Infection with M3neo with 1.5 mg ml-' Geneticin included in the
semi-solid medium.
In this study two retroviral vectors are systematically com-
pared for expression of GM-CSF in the FDCPI cell line.
These results indicate that the MoMLV based vector
pVneoGM is more efficient at expressing GM CSF in both
fibroblast and haematopoietic cells than the MPSV based
vector M3neoGM despite these vectors having equivalent
ability to confer geneticin resistance. The two major deter-
minants in the expression of exogenous material within the
vectors are the transcriptional promoters and whether sub-
genomic splicing is required (Gilboa, 1986gGory et a, 1987;
Magli et at., 1987). M3neoGM relies on the MPSV LTR for
expression of both the neo selectable marker and GM CSF
(splice type vector) (Laker et al. 1987), whereas pVneoGM
utilises both the MoMLV LTR and an intemal promoter to
control transcription of the GM CSF and neo sequences
respectively (double expression vector) (Lang et at 1985).
Splice type vectors have been shown to be inefficient at
expressing the second cistron of bixcistronic messages (Gory
et at., 1987; Laker et at., 1987( Lang et at, 1985) and the
lower GM-CSF activity from M3neoGM compared to
pVneoGM infected cells support this.
In order to compare the two vectors pVneoGM and
M3neoGM for their ability to express GM-CSF in
haematopoietic cells, the immature GM-CSF dependent
myeloid cell line FDCP1 (Dexter et al., 1980) was chosen as
a recipient for the vectors. The growth characteristics of
FDCP1 cells immediately after viral infection reveal that
pVneoGM converts a higher frequency of cells to factor
independence than M3neoGM (Table I). The analysis of cell
lines derived from infection uncovers a complexity hitherto
unobserved. FDCPI cell lines which contain the pVneoGM
virus and which were initially selected for geneticin resistance
demonstrate a variable and generally low replating efficiency
under conditions which select for factor independent growth
(Table III). This may relate to clonal variation in autocrine
directed GM-CSF stimulation, which may be sub-optimal for
efficient colony formation. Two FDCP1 clones which har-
boured pVneoGM increased their replating efficiency in re-
sponse to low levels of exogenous GM-CSF (Table IV). This
suggests autocrine stimulation is relatively inefficient yet
sufficient to convey a proliferative advantage over the paren-
tal FCDP1 cell line under sub-optimal growth conditions.
Geneticin-resistant FDCP1 cell lines derived after infection
with M3neoGM did not replate into growth factor indepen-
dent conditions (Table III). These data suggest that
M3neoGM expresses GM-CSF at a lower level than
pVneoGM and at a level incompatible with factor indepen-
dent clonal growth (Table III). The frequency with which
M3neoGM converts the factor dependent FDCP1 cell line to
factor independence is 50-fold lower than its ability to con-
vey geneticin resistance (Table I). Therefore, in infections
with M3neoGM virus many geneticin-resistant clones may
have to be screened in order to identify those releasing
sufficient GM-CSF to form colonies in the absence of
exogenous growth factor.
The two parental viruses, pVneo and M3neo were assessed
for their ability to infect and express the neomycin gene in
primary murine bone marrow. Both vectors were able to
generate geneticin-resistant CFU-GM progenitor colonies
and CFU-A in vitro stem cell colonies (Table V). This is the
first instance of the novel CFU-A assay (Pragnell et al., 1988)
being used as a test system for retroviral expression
experiments. The retroviral expression of genes in short term
in vitro assays may give some indication as to the multiple
steps involved in leukaemogenesis before, or as an alternative
to, more complex in vivo experiments. Therefore, the use of
short term in vitro assays to assess the efficiency of new
vectors in terms of gene expression in haematopoietic cells is
important. This study and others (Lang et al., 1985; Laker et
al., 1987) have gone some way to examine the efficiency of
retroviral vector mediated gene expression and address
whether autocrine stimulation results in a proliferative
advantage over non-autocrine stimulated cells.
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